NDC 73606-010

Empaveli

Pegcetacoplan

Empaveli is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Apellis Pharmaceuticals, Inc.. The primary component is Pegcetacoplan.

Product ID73606-010_bbd711fa-c1f0-458c-b916-230ac774f8dd
NDC73606-010
Product TypeHuman Prescription Drug
Proprietary NameEmpaveli
Generic NamePegcetacoplan
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2021-05-14
Marketing CategoryNDA /
Application NumberNDA215014
Labeler NameApellis Pharmaceuticals, Inc.
Substance NamePEGCETACOPLAN
Active Ingredient Strength1080 mg/20mL
Pharm ClassesComplement Inhibitor [EPC],Complement Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 73606-010-01

1 VIAL in 1 CARTON (73606-010-01) > 20 mL in 1 VIAL
Marketing Start Date2021-05-14
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Empaveli]

Mark Image

Registration | Serial
Company
Trademark
Application Date
EMPAVELI
EMPAVELI
97460836 not registered Live/Pending
Apellis Pharmaceuticals, Inc.
2022-06-15
EMPAVELI
EMPAVELI
90505492 not registered Live/Pending
Apellis Pharmaceuticals, Inc.
2021-02-02
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.